Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

15.0%

3 terminated/withdrawn out of 20 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 15 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

11(55.0%)

Phase 2

9(45.0%)

20Total

N/A(11)

Phase 2(9)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials

NCT07191288Not ApplicableRecruiting

Assessing the Acute Effects of Virtual Reality Interventions on Stress

Role: lead

NCT07191275Not ApplicableRecruiting

Study on the Effect of Transcranial Magnetic Stimulation on the Perception of Emotional Images

Role: lead

NCT05847933Not ApplicableCompleted

Influence of Temporo-occipital Transcranial Magnetic Brain Stimulation on Aversive Episodic Memory Performance

Role: lead

NCT04516603Phase 2Withdrawn

Influence of Fampridine on Working Memory in Healthy Subjects

Role: lead

NCT05274477Not ApplicableTerminated

Influence of Fampridine on Working Memory in Individuals With Post COVID-19 Condition With Subjective Cognitive Impairment

Role: lead

NCT06047899Not ApplicableCompleted

Influence of Luteolin for Two Weeks on Memory in Healthy Subjects

Role: lead

NCT04652557Phase 2Completed

Influence of Fampridine on Working Memory in Healthy Young Subjects

Role: lead

NCT03627117Not ApplicableCompleted

Influence of CBD on Episodic Memory in Healthy Subjects

Role: lead

NCT04162509Not ApplicableCompleted

Efficacy of a Gamified Augmented Reality Exposure-based Application in Subjects With Fear of Spiders

Role: lead

NCT03970187Not ApplicableCompleted

Investigation of the Efficacy of a VR Exposure-based Eye Contact Training‬ to Reduce Fear of Public Speaking

Role: lead

NCT04003753Not ApplicableCompleted

Efficacy of a VR Paradigm to Reduce Fear of Heights in a Clinical and Subclinical Population With Fear of Heights

Role: lead

NCT02935101Phase 2Terminated

Effects of Glucocorticoids on Craving During Detoxification Treatment of Heroin and/or Stimulants

Role: lead

NCT02789813Phase 2Completed

Influence of Valproic Acid on Extinction-based Therapy in Patients With Fear of Spiders.

Role: lead

NCT03382067Not ApplicableCompleted

Influence of Chocolate With Plant Additives on Episodic Memory in Healthy Subjects Experiencing Test Anxiety

Role: lead

NCT02904109Phase 2Completed

Influence of Triflusal on Cognitive Functions in Subjects Under Chronic Stress

Role: lead

NCT02321852Phase 2Completed

Influence of Triflusal on Cognitive Functions in Healthy Subjects

Role: lead

NCT01957293Phase 2Completed

Influence of Salbutamol on Emotional and Cognitive Functions in Healthy Subjects

Role: lead

NCT01718964Phase 2Completed

Acute Effects of Cortisol on Heroin Craving in Opioid Dependence (Ghost-Basel)

Role: lead

NCT01599962Phase 2Completed

Influence of Cincalcet on Cognitive Functions in Healthy Human Subjects

Role: lead

NCT01321021Not ApplicableCompleted

Influence of Losartan and Diphenhydramine on Emotional and Cognitive Functions in Healthy Human Subjects

Role: lead

All 20 trials loaded